Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Oct 14, 2016; 22(38): 8558-8567
Published online Oct 14, 2016. doi: 10.3748/wjg.v22.i38.8558
Figure 2
Figure 2 Overall SVR12 rate was 93% and 95% in patients who had completed the intention-to-treat and per protocol analysis respectively. SVR: Sustained virologic response.